Page 32 - Journal of Structural Heart Disease Volume 4, Issue 5
P. 32

227
Original Scientific Article
  6. Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, et al. Closure or Med- ical Therapy for Cryptogenic Stroke with Patent Foramen Ovale. N. Engl. J. Med. 2012;366:991–999.
7. Søndergaard L, Kasner SE, Rhodes JF, An- dersen G, Iversen HK, Nielsen-Kudsk JE, et al. Patent Foramen Ovale Closure or Anti- platelet Therapy for Cryptogenic Stroke. N. Engl. J. Med. 2017;377:1033–1042. DOI: 10.1056/NEJMoa1707404
8. Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, et al. Long- Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke. N. Engl. J. Med. 2017;377:1022–1032.
9. Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, et al. Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke. N. Engl. J. Med. 2013;368:1092–1100. DOI: 10.1056/ NEJMoa1301440
10. Caldwell DM, Ades AE, Higgins JPT. Simul- taneous comparison of multiple treat- ments: combining direct and indirect
evidence. BMJ. BMJ Publishing Group.
2005;331:897–900.
11. Brooks SP, Gelman A. General Methods
for Monitoring Convergence of Itera- tive Simulations. J. Comput. Graph. Stat. 1998;7:434–455.
12. Brown S, Hutton B, Clifford T, Coyle D, Grima D, Wells G, et al. A Microsoft-Ex- cel-based tool for running and critically appraising network meta-analyses—an overview and application of NetMetaXL. Syst. Rev. BioMed Central. 2014;3:110.
13. Stettler C, Allemann S, Wandel S, Kastrati A, Morice MC, Schömig A, et al. Drug elut- ing and bare metal stents in people with and without diabetes: collaborative net- work meta-analysis. BMJ. 2008;337. DOI: 10.1136/bmj.a1331
14. Dias S, Welton NJ, Sutton AJ, Caldwell DM, Lu G, Ades AE. Evidence Synthesis for De- cision Making 4. Med. Decis. Mak. SAGE Publications, Sage CA: Los Angeles, CA; 2013;33:641–656.
15. Caldwell DM, Ades AE, Higgins JPT. Simul- taneous comparison of multiple treat-
16.
ments: combining direct and indirect evidence. BMJ. 2005;331:897–900. DOI: 10.1136/bmj.331.7521.897
Mojadidi MK, Elgendy AY, Elgendy IY, Mah- moud AN, Elbadawi A, Eshtehardi P, et al. Transcatheter Patent Foramen Ovale Clo- sure After Cryptogenic Stroke. JACC Car- diovasc. Interv. 2017;10:2228–2230. DOI: 10.1016/j.jcin.2017.09.002
   Mina G. et al.
Meta-Analysis of PFO Closure for Stroke Prevention
Cite this article as: Mina GS, Soliman D, Modi K. Patent Foramen Ovale Clo- sure for Recurrent Stroke Prevention: A Network Meta-Analysis of Randomized Controlled Trials. Structural Heart Dis- ease. 2018;4(5):222-227. DOI: https:// doi.org/10.12945/j.jshd.2018.047.17














































































   30   31   32   33   34